Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Notification according to chapter 9, section 5 and 6 of the Securities Market Act: BlackRock, Inc ownership in Valmet excluding shares and voting rights through financial instruments below 5 percent

Valmet Oyj's stock exchange release on March 25, 2019 at 11.00 a.m. EET Valmet Oyj has on March 22, 2019 received a notification referred to in Securities Market Act from BlackRock, Inc, stating that the company's ownership and share of votes in Valmet Oyj excluding shares and voting rights through financial instruments has fallen below the threshold of 5 percent.                                                                                                                         As a result of transactions on March 21, 2019, the total holding of BlackRock, Inc decreased to 8,429,

Decisions of the Extraordinary General Meeting of CapMan Plc

CapMan Plc Stock Exchange Release 25 March 2019 at 10.45 a.m. EET Decisions of the Extraordinary General Meeting of CapMan Plc The Extraordinary General Meeting (EGM) of CapMan Plc was held today in Helsinki. The EGM approved the proposal of the Board of Directors concerning the repayment of equity from the invested unrestricted equity fund. The Extraordinary General Meeting decided in accordance with the proposal of the Board of Directors that EUR 0.06 per share be returned from the invested unrestricted equity fund of CapMan Plc. The equity repayment will be paid to shareholders

Notice of Annual General Meeting of Shareholders in NeuroVive Pharmaceutical AB (publ)

The Board of Directors of NeuroVive Pharmaceutical AB (publ) has issued a notice to the Annual General Meeting, which is to take place on Thursday, April 25, 2019, at 4 pm at Medicon Village, Scheelevägen 2 in Lund, Sweden.Please see the attached notification, which is being announced within short in Svenska Dagbladet and Post- och Inrikes Tidningar. NeuroVive Pharmaceutical AB (publ)Medicon Village, SE-223 81 Lund, SwedenTel: +46 (0)46 275 62 20 (switchboard)info@neurovive.com, www.neurovive.comFor news subscription, please visit http://www.neurovive.com/press-releases/

Company Announcement No. 34, 2019 – Debtor composition in Nordea Kredit (CK 92)

Monthly information on debtor composition in Nordea Kredit published in order to comply with the Transparency Directive's disclosure requirements.Nordea Kredit hereby publishes monthly data on debtor composition of all callable bond series. The information is subject to disclosure requirements in the Securities Trading Act § 27a section 1.The information is also published in the usual way via the Copenhagen Stock Exchange / OMX.  Nordea Kredit Realkreditaktieselskab   Bo Dam Klausen Phone : +45 55 47 31 42

Twenty-two Excellent Researchers Chosen to be Wallenberg Scholars

The researchers – among the foremost in their field in Sweden – receive SEK 18 million each from the Wallenberg Foundations in the form of a five-year grant for free research.Jumping genes, antibiotics resistance, new therapies for infections, diabetes and Parkinson’s disease, secure technology for wireless communication, self-repairing batteries, a better understanding of climate change, and searching for Earth-like planets are examples of the research that will be conducted by some of the twenty-two Wallenberg Scholars. “Free research is what it sounds like. The researchers’ own

Siemens extends industry leading Simcenter simulation and test offering with acquisition of noise, vibration and harshness business from Saab Medav

· Asset deal strengthens Siemens’ Simcenter portfolio with a range of innovative and highly configurable solutions for end-of-line noise, vibration, and harshness (NVH) quality testing · Quality testing results from Saab Medav systems will provide valuable input to the product digital twin, supporting continuous product improvement and development · Saab Medav’s NVH team and technology complement the Simcenter test portfolio to enable customers to systematically improve overall product and manufacturing qualitySiemens announced today that it has signed an agreement to acquire the

Not a Single Story II at Wanås Konst 2019 – full list of artists announced

The Wanås Foundation is pleased to present all artists participating in Not a Single Story II. The exhibition opens in the Wanås Konst sculpture park and Art Gallery on May 5, 2019. The “story” as a concept, the participating artists, their practices, and how they relate to the site comprise the central elements of this exhibition. The starting point and inspiration for the title comes from author Chimamanda Ngozi Adichie’s well-known Ted Talk, which she begins: “I am a storyteller. And I would like to tell you a few personal stories about what I like to call ‘the danger of the single story’.”

Annual General Meeting in BE Group AB

Shareholders in BE Group AB (publ), reg. no. 556578-4724, are hereby invited to attend the Annual General Meeting to be held at 3.00 p.m. on Thursday 25 April 2019, at Malmö Börshus, Skeppsbron 2 in Malmö. Right to attend Shareholders who wish to attend the Annual General Meeting must: (i)  be recorded in the share register kept by Euroclear Sweden AB on Wednesday 17 April 2019and(ii) notify the company of their intention to attend the meeting no later than on Wednesday 17 April 2019, preferably before 12.00 noon. In order to participate in the meeting, shareholders with

REVOLUTIONARY POWER TECHNOLOGY SHOWCASED IN DUBLIN AS PART OF CROSS-EUROPEAN TOUR

A revolutionary mobile power flow control unit which can significantly increase the amount of renewable energy that electricity grids can accommodate, was showcased in Dublin. Smart Wires mobile unit leverages modular power flow control technology developed by pioneering power technology company, Smart Wires, whose European headquarters are based in Ballyfermot, Dublin. The mobile unit, which is the size of a semi-trailer, is traveling from the USA to Greece’s Peloponnese region, where it will be deployed on the Greek Transmission System. It heralds a new era in the use of

SEK 20 million for new sustainable transportation solutions

A transition of the transport sector will require new solutions and a changed market. As part of the process to achieve its fossil-free targets by 2030, Södra is now earmarking an investment of SEK 20 million for the additional costs arising from the choice of new and sustainable transport solutions“As one of Sweden’s largest transport purchasers, we have a major responsibility. We want to show the way to a sustainable transport future and this investment will show that we are very serious about achieving change, and inspiring others to follow our lead,” said Lars Idermark, President and

Advenica receives order for cybersecurity products from European Space Agency

Advenica, a leading European provider of cybersecurity solutions, has received an order for both encryption products and Cross Domain Solutions from the European Space Agency (ESA).Advenica provides expertise and unique, technically advanced, durable and future-proof high assurance cybersecurity solutions for critical data in motion up to Top Secret classification. The company has its head office in Malmö, Sweden and established itself in Austria in mid-2017 to provide high-security cybersecurity solutions to customers in Austria and other European countries. The Austrian office has now

Norrlands Universitetssjukhus starts study with OnZurf Probe

Press release: Uppsala, March 25, 2019, Senzime (PUBL) today announces that Norrlands Universitetssjukhus has initiated a new exploratory pilot study with OnZurf probe. The study will include a total of 30 patients undergoing liver surgery. The study aims to further demonstrate the benefits of organ-specific, continuous measurement of metabolic markers. Early detection of lactate withdrawal is an established marker of oxygen deficiency and possible complication. By continuously monitoring changes of different metabolites in the liver with OnZurf Probe, the prerequisites are to

Ripasso Energy changes its name to Swedish Stirling

The board of Swedish clean tech company Ripasso Energy AB has resolved to propose to the General Assembly on 26 April that the company changes its name to Swedish Stirling AB. The reason for the proposal is that the company expects to achieve a commercial breakthrough in the coming years.The board of Swedish clean tech company Ripasso Energy AB believes that the company will achieve a commercial breakthrough over the next few years. In view of this, the board is proposing to the General Assembly that the company changes its name to Swedish Stirling, which more clearly describes the company'

NOTICE OF ANNUAL GENERAL MEETING IN BIOTAGE AB (publ)

The shareholders in Biotage AB (publ), Reg. No. 556539-3138, with its registered office in Uppsala kommun, Uppsala län, are hereby summoned to the annual general meeting (the “Meeting”), to be held on Wednesday, April 24, 2019, at 4.00 p.m., at Hotel Radisson Blue in Uppsala, Stationsgatan 4 in Uppsala, Sweden. Notice, etc.Shareholders who wish to participate in the Meeting musta) be recorded as a shareholder in the share register maintained by Euroclear Sweden AB on Tuesday, April 16, 2019, andb) notify the company of their intention to participate in the Meeting, no later than

Biotage AB –Nomination Committee proposal for the election of Board of Directors and Chairman of the Board

Stockholm, Biotage AB (Biotage), (NASDAQ OMX Stockholm: BIOT.ST) – the Nomination Committee of Biotage AB announces its proposal for the election of the Board of Directors and Chairman of the Board for the forthcoming Annual General Meeting (“AGM”).The Nomination Committee proposes: · that the Board of Directors shall consist of six Directors elected by the AGM, · re-election of the current Directors of the Board Peter Ehrenheim, Thomas Eklund and Karolina Lawitz. Nils-Olof Björk, and Yvonne Mårtensson have declined re-election, · election of Reinhard Vogt, Mark Bradley and

Sobi and Novimmune selected as Honourees for 2019 National Organization for Rare Disorders (NORD) Rare Impact Award in Industry Innovation for Gamifant® (emapalumab)

Sobi™ and Novimmune SA have both been selected as honourees by the National Organization for Rare Disorders (NORD) for the 2019 Rare Impact Awards. The companies were nominated in the category of Industry Innovation in recognition of the US Food and Drug Administration (FDA) approval in November 2018 of Gamifant® (emapalumab-lzsg) for the treatment of paediatric (newborn and older) and adult patients with primary haemophagocytic lymphohistiocytosis (HLH) with refractory, recurrent or progressive disease or intolerance to conventional HLH therapy. The Rare Impact Awards recognise

The Nomination Committee of Handicare Group has decided to propose a new member of the Board

Ahead of the Annual General Meeting held on May 8th, 2019 the Nomination Committee of Handicare Group has decided to propose Christina Lindstedt as new director of the Board in Handicare Group.The Nomination Committee proposes that the Board shall be composed of seven directors (unchanged from the current year) elected at the Annual General Meeting, with no deputy members, for the period until the next Annual General Meeting. The Nomination Committee proposes re-election of Lars Marcher, Joakim Andreasson, Jonas Arlebäck, Maria Carell, Johan Ek, Claes Magnus Åkesson and Christina

Finns choose a domestic nicotine-free product as their preferred smoking intervention method

Biohit Oyj and Sanoma Media invited 40 volunteers  to try and quit smoking by using Acetium® lozenge and asked for feedback on their experience of using this alternative method. They received encouraging and positive comments from the users and with the help of Acetium, 93% of the test group reduced smoking significantly or quit smoking completely during the two months of testing. Based on the test group, most people trying to quit smoking are concerned about their health and want to put an end to unnecessary spending. 89% of the test group felt that Acetium® lozenge being nicotine-free

Inhalation Sciences' PreciseInhale center stage at packed Fraunhofer ITEM seminar, SOT 2019

Fraunhofer ITEM (Institute for Toxicology and Experimental Medicine) is one of the world’s leading toxicology research organizations. At the SOT (Society of Toxicology) 2019 Conference in Baltimore it presented innovative research carried out using Inhalation Sciences’ PreciseInhale, to over 100 scientists at a packed exhibitor-hosted seminar.“It was an early seminar right at the beginning of the day—but it was packed” says ISAB CEO Lena Heffler. “The seminar presented PreciseInhale and highly innovative research into animal-free testing carried out using it. The general response was that

Wallenstam selected to participate in the development of Landvetter Södra

Wallenstam will be one of the six construction and property companies that will develop Landvetter Södra together with Landvetter Södra Utveckling AB and Härryda Municipality. Landvetter Södra will be built in a strategic location between Gothenburg and Borås, close to Gothenburg Landvetter Airport. It will be a modern, international, innovative and humane town for at least 25,000 inhabitants.“It feels really great for us to be involved from the start and participate in the development of Landvetter Södra. The plan for Landvetter Södra is to build innovatively and sustainably in line with

Insplorion won the ABB SynerLeap Springboard and expanded its collaboration

Insplorion won, together with Omnio, ABB SynerLeap Springboard in 2019. Now we are developing the cooperation with ABB through a joint project paid by ABB with USD 30,000. The project will investigate process monitoring primarily for water purification. We also win offices at Synerleap, central in Västerås, with direct access to ABB's organization. In our cooperation other areas of interest, in addition to previous battery sensors, are also various types of gas measurements, for example hydrogen gas.SynerLeap is ABB's innovation development hub for startups with its head office located in

Fortum solves major EV sustainability issue - innovation boosts battery recycling rate to over 80%

FORTUM CORPORATION PRESS RELEASE 25 March 2019 Electrification will rapidly increase the need for batteries. A new solution by Nordic clean energy company Fortum makes over 80% of the electric vehicle (EV) battery recyclable, returns the scarce metals back into circulation and resolves the sustainability gap by reducing the need to mine cobalt, nickel, and other scarce metals. "There are very few working, economically viable technologies for recycling the majority of materials in lithium-ion batteries. We saw a challenge that was not yet solved and developed a scalable recycling

HIDDN: Enters into a LOI for a potential business combination with Energos Group, to diversify business to include renewable energy technology.

(Oslo, 25 March 2019) Hiddn Solutions ASA (Hiddn, OSE: HIDDN) has entered into a Letter of Intent (LOI) for a potential business combination with Energos Group AS (Energos) to add new business lines providing technology and solutions to the global renewable energy production industry. “We are pleased to announce the ambition to join forces with Energos to further develop and fuel the growth of an already strong and profitable business line within supplying technology and solutions for renewable energy production. Energos has a solid platform in this global industry and we look forward to

BioArctic’s partner Eisai to give poster presentations on BAN2401 in early Alzheimer’s disease at the AD/PD conference in Lisbon

Stockholm, Sweden, March 25, 2019 – BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) announces that its partner Eisai will give poster presentations related to BAN2401 in early Alzheimer’s disease at the 14th International Conference on Alzheimer’s & Parkinson’s Diseases (AD/PD) on March 27 in Lisbon, Portugal. One poster presentation will highlight the study design for the Open Label Extension portion of the BAN2401 Phase 2b study in patients with early Alzheimer’s disease. Another poster presentation will cover pharmacokinetic and exposure-response analyses for efficacy and safety of

There are no items matching the current filter
There are no more items matching the current filter
Back to top